103 related articles for article (PubMed ID: 9366280)
1. How should we treat hypertensive women with cardiac and renal impairment?
Ruilope LM; Suarez C
Am J Hypertens; 1997 Oct; 10(10 Pt 2):242S-246S. PubMed ID: 9366280
[TBL] [Abstract][Full Text] [Related]
2. Comparison of quinapril versus atenolol: effects on blood pressure and cardiac mass after renal transplantation.
Suwelack B; Gerhardt U; Hausberg M; Rahn KH; Hohage H
Am J Cardiol; 2000 Sep; 86(5):583-5, A10. PubMed ID: 11009288
[TBL] [Abstract][Full Text] [Related]
3. Regression of left ventricular hypertrophy and improvement of renal hemodynamics in hypertensive patients treated with quinapril.
De Caprio L; De Rosa ML; Di Palma A; Lirato C; Caccese P; Sestito M; Lastoria S; Cicatiello AM; Rengo F
Cardiovasc Drugs Ther; 1994 Oct; 8(5):735-40. PubMed ID: 7873470
[TBL] [Abstract][Full Text] [Related]
4. Effects of quinapril hydrochloride in patients with essential hypertension and impaired renal function.
Owada A; Nonoguchi H; Terada Y; Marumo F; Tomita K
Clin Exp Hypertens; 1997 May; 19(4):495-502. PubMed ID: 9140710
[TBL] [Abstract][Full Text] [Related]
5. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
[TBL] [Abstract][Full Text] [Related]
6. Hypertension and Organ Damage in Women.
Muiesan ML; Paini A; Aggiusti C; Bertacchini F; Rosei CA; Salvetti M
High Blood Press Cardiovasc Prev; 2018 Sep; 25(3):245-252. PubMed ID: 29943358
[TBL] [Abstract][Full Text] [Related]
7. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
Larochelle P; Haynes B; Maron N; Dugas S
Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244
[TBL] [Abstract][Full Text] [Related]
8. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
[TBL] [Abstract][Full Text] [Related]
9. The Role of Beta-Blockers in the Treatment of Hypertension.
Cruickshank JM
Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
[TBL] [Abstract][Full Text] [Related]
10. Effect of quinapril on the albumin excretion rate in patients with mild to moderate essential hypertension. Multicenter Study Group.
Larochelle P
Am J Hypertens; 1996 Jun; 9(6):551-9. PubMed ID: 8783779
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
[TBL] [Abstract][Full Text] [Related]
12. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Devereux RB; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
[TBL] [Abstract][Full Text] [Related]
13. Effect of quinapril therapy on blood pressure and serotonin change in patients with mild to moderate hypertension.
Huang JL; Cheng FC; Chen YT; Ting CT
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):329-34. PubMed ID: 9037848
[TBL] [Abstract][Full Text] [Related]
14. Effect of quinapril versus nitrendipine on endothelial dysfunction in patients with systemic hypertension.
Uehata A; Takase B; Nishioka T; Kitamura K; Akima T; Kurita A; Isojima K
Am J Cardiol; 2001 Jun; 87(12):1414-6. PubMed ID: 11397368
[No Abstract] [Full Text] [Related]
15. Randomly allocated study of the effects of standard therapy versus ACE inhibition on micro-albuminuria in essential hypertension.
Ruilope LM; Lahera V; Alcázar JM; Praga M; Campo C; Rodicio JL
J Hypertens Suppl; 1994 Jul; 12(4):S59-63. PubMed ID: 7965276
[TBL] [Abstract][Full Text] [Related]
16. Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive rats.
Panizo A; Pardo J; Hernández M; Galindo MF; Cenarruzabeitia E; Díez J
Am J Hypertens; 1995 Aug; 8(8):815-22. PubMed ID: 7576398
[TBL] [Abstract][Full Text] [Related]
17. Goals of antihypertensive therapy.
McVeigh GE; Flack J; Grimm R
Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
[TBL] [Abstract][Full Text] [Related]
18. Modification of cardiovascular risk factors during antihypertensive treatment: a multicentre trial with quinapril.
Manzato E; Capurso A; Crepaldi G
J Int Med Res; 1993; 21(1):15-25. PubMed ID: 8319817
[TBL] [Abstract][Full Text] [Related]
19. Current drug treatment and treatment patterns with antihypertensive drugs.
Freis ED; Papademetriou V
Drugs; 1996 Jul; 52(1):1-16. PubMed ID: 8799681
[TBL] [Abstract][Full Text] [Related]
20. Quinapril reduces arterial blood pressure and improves metabolic control in elderly hypertensive diabetic patients.
Paolisso G; Gambardella A; Verza M; Varricchio M
Diabete Metab; 1990; 16(3):264-5. PubMed ID: 2210025
[No Abstract] [Full Text] [Related]
[Next] [New Search]
